Literature DB >> 14611926

Number of dementia sufferers in Europe between the years 2000 and 2050.

Johannes Wancata1, M Musalek, R Alexandrowicz, M Krautgartner.   

Abstract

Several authors have pointed out that in the next few decades dementia will affect a considerably increasing number of the elderly. To our knowledge there exist no calculations of the number of demented persons for the whole European region. We made calculations on the number of dementia cases for the period 2000-2050 based on the population projections of the United Nations. For this purpose, we used the results of several meta-analyses of epidemiological studies. The number of prevalent dementia cases in the year 2000 was 7.1 million. Within the next 50 years, this number will rise to about 16.2 million dementia sufferers. The number of new dementia cases per year will increase from about 1.9 million in the year 2000 to about 4.1 million in the year 2050. Contrarily, the working-age population will considerably decrease during the next 50 years. In the year 2000, 7.1 million dementia cases faced 493 million persons in working-age. This equals a ratio of 69.4 persons in working-age per one demented person. Until the year 2050, this ratio will decrease to only 21.1. Thus, the financial and emotional burden placed by dementia on the working-age population will markedly rise.

Entities:  

Mesh:

Year:  2003        PMID: 14611926     DOI: 10.1016/j.eurpsy.2003.03.003

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  26 in total

1.  Informal caregivers of persons with dementia, their use of and needs for specific professional support: a survey of the National Dementia Programme.

Authors:  José M Peeters; Adriana Pa Van Beek; Anneke L Francke; Julie Hcm Meerveld; Peter Mm Spreeuwenberg
Journal:  BMC Nurs       Date:  2010-06-07

2.  Age-related predictors of institutionalization: results of the German study on ageing, cognition and dementia in primary care patients (AgeCoDe).

Authors:  Melanie Luppa; Steffi G Riedel-Heller; Tobias Luck; Birgitt Wiese; Hendrik van den Bussche; Franziska Haller; Melanie Sauder; Edelgard Mösch; Michael Pentzek; Anja Wollny; Marion Eisele; Thomas Zimmermann; Hans-Helmut König; Wolfgang Maier; Horst Bickel; Jochen Werle; Siegfried Weyerer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-12-23       Impact factor: 4.328

Review 3.  Epidemiology and risk factors of dementia.

Authors:  W M van der Flier; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  Filial maturity as a predictor for the burden of demented parents' caregivers.

Authors:  G Stiens; L Maeck; G Stoppe
Journal:  Z Gerontol Geriatr       Date:  2006-04       Impact factor: 1.281

5.  Long-term cost-effectiveness of donepezil for the treatment of Alzheimer's disease.

Authors:  Stefan J Teipel; Michael Ewers; Veronika Reisig; Bernd Schweikert; Harald Hampel; Michael Happich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-01       Impact factor: 5.270

Review 6.  [Community-based psychosocial care for people with dementia].

Authors:  Günter Klug; Christian Jagsch
Journal:  Z Gerontol Geriatr       Date:  2017-10-05       Impact factor: 1.281

7.  [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].

Authors:  T Möller; C Born; M F Reiser; H-J Möller; H Hampel; S J Teipel
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

Review 8.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

9.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

10.  WHEDA study: effectiveness of occupational therapy at home for older people with dementia and their caregivers--the design of a pragmatic randomised controlled trial evaluating a Dutch programme in seven German centres.

Authors:  Sebastian Voigt-Radloff; Maud Graff; Rainer Leonhart; Katrin Schornstein; Myrra Vernooij-Dassen; Marcel Olde-Rikkert; Michael Huell
Journal:  BMC Geriatr       Date:  2009-10-02       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.